Researchers have linked herpes simplex virus-1 with Alzheimer's disease, revealing a surprising potential viral trigger for the neurodegenerative condition. Their study suggests that the tau protein, ...

Johnson & Johnson on Wednesday said it has won Food and Drug Administration fast-track designation for its proposed posdinemab treatment for Alzheimer's disease. J&J is investigating the internally ...